首页> 外国专利> METHOD AND KIT FOR ESTABLISHING, IN VITRO, A PROGNOSIS OF SEVERITY IN A SEPTIC SHOCK PATIENT

METHOD AND KIT FOR ESTABLISHING, IN VITRO, A PROGNOSIS OF SEVERITY IN A SEPTIC SHOCK PATIENT

机译：建立静息震荡患者严重程度的预后的方法和工具包

展开▼

页面导航

摘要

著录项

相似文献

摘要

The invention concerns a method for establishing, in vitro, a prognosis of severity in a septic shock patient, comprising the following steps: (i) using a biological sample taken from said patient, measuring, in vitro, the level of expression of the expression product of at least one gene chosen from the lilrb2 and lilrb1 genes, (ii) comparing the level of expression of the expression product of said at least one gene with a control level of expression of the expression product of the same gene indicating a good prognosis of severity, in which a level of expression of the expression product of said at least one gene that is lower than said control level of expression indicates a poor prognosis of severity for the patient, and a kit for implementing the method. 展开▼

机译：本发明涉及一种在体外建立败血性休克患者严重程度预后的方法，该方法包括以下步骤：（i）使用从所述患者中获取的生物样品，测量，从 lilrb2 和 lilrb1 基因中选择的至少一种基因的表达产物的表达水平，（ii）比较表达水平所述至少一种基因的表达产物的表达水平与同一基因的表达产物的对照表达水平相比，表明严重程度的预后良好，其中所述至少一种基因的表达产物的表达水平较低相对于所述对照表达水平而言，表明患者严重程度的预后不良，以及用于实施该方法的试剂盒。 展开▼

著录项

公开/公告号WO2014108646A1

专利类型

公开/公告日2014-07-17

原文格式PDF

申请/专利权人 BIOMÉRIEUX;HOSPICES CIVILS DE LYON;
展开▼

申请/专利号WO2014FR50039

发明设计人 MONNERET GUILLAUME;CAZALIS MARIE-ANGÉLIQUE;LEPAPE ALAIN;TOURNOUD MAUD;VENET FABIENNE;
展开▼

申请日2014-01-10

分类号C12Q1/68;

国家 WO

入库时间 2022-08-21 15:48:29

相似文献

专利

外文文献

中文文献

1. 建立HAIC治疗晚期肝癌患者预后模型的方法 [P] . 中国专利： CN113362885A . 2021-09-07

2. 转移性去势抵抗性前列腺癌患者在阿比特龙治疗中的预后预测模型及其建立方法和应用 [P] . 中国专利： CN112687394A . 2021-04-20

3. Method and kit for in vitro establishing a prognosis of severity in a patient with septic shock [P] . ES2642056T3 . 2017-11-15

机译：在体外确定败血性休克患者严重程度的方法和试剂盒

4. METHOD AND KIT FOR ESTABLISHING, IN VITRO, A PROGNOSIS OF SEVERITY IN A SEPTIC SHOCK PATIENT [P] . 欧洲知识产权局专利： EP2943588A1 . 2015-11-18

机译：建立癫痫严重程度的预后的体外方法和工具包

5. METHOD AND KIT FOR ESTABLISHING IN VITRO A PROGNOSIS OF SEVERITY IN A SEPTIC SHOCK PATIENT [P] . 法国专利： FR3000966A1 . 2014-07-18

机译：建立癫痫严重程度的预后的体外方法和工具包

1. Shock——Effect of dopamine combined with norepinephrine on the renal function in patients with septic shock [J] . 侯立朝中国医学文摘：外科学分册英文版 . 2006,第004期

2. Raoultella planticolaBacteremia-Induced Fatal Septic Shock and Sepsis-Induced Coagulopathy in a Patient with Pancreatic Cancer: A Case Report and Literature Review [J] . Konul Hajiyeva, Mehmet Oral 临床医学国际期刊（英文） . 2021,第001期

3. Predictive value of serum lactate dehydrogenase in diagnosis of septic shock in critical pediatric patients:A cross-sectional study [J] . HebatAllah Fadel Algebaly, Ahmed Abd-Elal, Rasha El Kaffas, 急性病杂志(英文版) . 2021,第003期

4. Efficacy and safety of corticosteroids in immunocompetent patients with septic shock [J] . Xin Lu, Wei Han, Yan-xia Gao, 世界急诊医学杂志(英文版) . 2021,第002期

5. Effect of two volume responsiveness evaluation methods on fluid resuscitation and prognosis in septic shock patients [J] . Xu Qianghong, Yan Jing, Cai Guolong, 中华医学杂志（英文版） . 2014,第003期

6. Association of Peripheral Lymphocyte Subset with the Severity and Prognosis of Septic Shock [J] . ??????????????????? Acute and critical care. . 2011,第1期

7. Corporeal Compression at the Onset of Septic shock (COCOONs): a compression method to reduce fluid balance of septic shock patients [J] . Auguste Dargent, Audrey Large, Agnès Soudry-Faure, Scientific reports. . 2019,第1期

8. On Computer-Aided Prognosis of Septic Shock from Vital Signs [C] . Hasan Oğul, Alejandro Baldominos, Tunç Aşuroğlu, IEEE International Symposium on Computer-Based Medical Systems . 2019

9. Integration of Recognition, Diagnostic, and Treatment Strategies between Prehospital Emergency Medical Services and Hospital Emergency Departments in the Management of Patients with Acute Sepsis and Septic Shock [D] . Duguay, Darren Caine. 2019

10. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. [O] . J E Parrillo, C Burch, J H Shelhamer, 1985

11. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. [O] . Parrillo, J E, Burch, C, Shelhamer, J H, 1985

1. Timing,method and discontinuation of hydrocortisone administration for septic shock patients [J] . Miguel A Ibarra-Estrada12 ,Quetzalcoatl Chavez-Pena34 ,Claudia I Reynoso-Estrella5 . 世界重症医学杂志 . 2017,第001期

2. 决策树方法在静息心电图ST-T改变及静息时心率与冠状动脉疾病的严重程度的关系分析的应用 [C] . . 2016年中国生物统计学术年会 . -1

3. 脑震荡综合征患者内侧前额叶皮质功能连接变化的静息态fMRI研究 [A] . 魏荣胜 . 2017